SCHEMBL21592437

SCHEMBL21592437

CN(C)Cc1ccc(-c2c[nH]c3ncc(-c4ccc(N5CCN(C)CC5)cc4)nc23)cc1

nearest known ligand 0.65

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 5/20 0.65
MAPK1 P28482 10/20 0.46
CLK1 P49759 2/20 0.46
DYRK1A Q13627 2/20 0.46
PIM1 P11309 1/20 0.44
PIM3 Q86V86 1/20 0.44
PIM2 Q9P1W9 1/20 0.44
IL2 P60568 1/20 0.43
RPS6KA3 P51812 1/20 0.41
ACVRL1 P37023 1/20 0.41
ACVR1 Q04771 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21592496 0.87 MAP4K1 (0.68) MAP4K1MAPK1IL2RPS6KA3
SCHEMBL21592575 0.85 MAP4K1 (0.67) MAP4K1MAPK1CLK1DYRK1AIL2
SCHEMBL28504546 0.85 MAP4K1 (0.70) MAP4K1MAPK1IL2RPS6KA3
SCHEMBL28509493 0.84 MAP4K1 (0.69) MAP4K1MAPK1IL2RPS6KA3
SCHEMBL21593065 0.83 MAP4K1 (0.68) MAP4K1MAPK1CLK1DYRK1AIL2
SCHEMBL21592474 0.83 MAP4K1 (0.77) MAP4K1MAPK1PIM1IL2RPS6KA3
SCHEMBL21592571 0.83 MAP4K1 (0.62) MAP4K1MAPK1IL2RPS6KA3
SCHEMBL21592435 0.83 MAP4K1 (0.77) MAP4K1MAPK1CLK1DYRK1A
SCHEMBL21592718 0.82 MAP4K1 (0.67) MAP4K1MAPK1CLK1DYRK1AIL2
SCHEMBL21592460 0.82 MAP4K1 (0.67) MAP4K1MAPK1IL2RPS6KA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112243439-A Pyrrolo [2,3-B ] pyridines or pyrrolo [2,3-B ] pyrazines as HPK1 inhibitors and uses thereof 百济神州有限公司 2021-01-19 CN disclosed
WO-2019238067-A1 PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF BEIGENE, LTD. (KY) 2019-12-19 WO disclosed